A Prospective, Phase I/II, Open-Label Pilot Trial to Assess the Safety of Hyperthermic Intraperitoneal Chemotherapy After Oncological Resection of Pancreatic Adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a common fatal disease with unfavorable prognosis, even after oncological resection. To improve survival, adding hyperthermic intraperitoneal chemotherapy (HIPEC) has been suggested. Whether HIPEC entails disproportional short-term mortality is...

Descripción completa

Detalles Bibliográficos
Autores principales: Yurttas, Can, Horvath, Philipp, Fischer, Imma, Meisner, Christoph, Nadalin, Silvio, Königsrainer, Ingmar, Königsrainer, Alfred, Beckert, Stefan, Löffler, Markus W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Peritoneal Surface Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205203/
https://www.ncbi.nlm.nih.gov/pubmed/34131821
http://dx.doi.org/10.1245/s10434-021-10187-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205203/
https://www.ncbi.nlm.nih.gov/pubmed/34131821
http://dx.doi.org/10.1245/s10434-021-10187-8

Ejemplares similares